Advance Search | Bentham Science

Small Molecule Kinase Inhibitors as Anti-Cancer Therapeutics

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 12 Issue: 5 Year: 2012 Page: 399-411
Author(s): O. Chahrour,D. Cairns,Z. Omran

JAK2 Inhibitors for Myelofibrosis: Why are They Effective in Patients with and Without JAK2V617F Mutation?

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 9 Year: 2012 Page: 1098-1109
Author(s): Fabio P. S. Santos,Srdan Verstovsek

Myeloproliferative Neoplasms Including Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis, Chronic Neutrophilic Leukemia, and Myeloproliferative Neoplasm, Unclassifiable

Journal: Current Cancer Therapy Reviews
Volume: 8 Issue: 1 Year: 2012 Page: 14-29
Author(s): Robert P. Hasserjian

Novel Targets and Derived Small Molecule Inhibitors in Multiple Myeloma

Journal: Current Cancer Drug Targets
Volume: 12 Issue: 7 Year: 2012 Page: 797-813
Author(s): Klaus Podar

The 2010 Patent Landscape for Spleen Tyrosine Kinase Inhibitors+

Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 6 Issue: 2 Year: 2012 Page: 97-120
Author(s): Alessandro F. Moretto,Christoph Dehnhardt,Neelu Kaila,Nikolaos Papaioannou,Atli Thorarensen

Biology and Clinical Management of Myeloproliferative Neoplasms and Development of the JAK Inhibitor Ruxolitinib

Journal: Current Medicinal Chemistry
Volume: 19 Issue: 2 Year: 2012 Page: 4399-4413
Author(s): J. Mascarenhas, T. I. Mughal, S. Verstovsek

CuAAC Click Chemistry Accelerates the Discovery of Novel Chemical Scaffolds as Promising Protein Tyrosine Phosphatases Inhibitors

Journal: Current Medicinal Chemistry
Volume: 19 Issue: 15 Year: 2012 Page: 2399-2405
Author(s): X. -P. He, J. Xie, Y. Tang, J. Li, G. -R. Chen

Preclinical Metabolism and Pharmacokinetics of SB1317 (TG02), a Potent CDK/JAK2/FLT3 Inhibitor

Journal: Drug Metabolism Letters
Volume: 6 Issue: 1 Year: 2012 Page: 33-42
Author(s): Mohammed Khalid Pasha, Ramesh Jayaraman, Venkatesh Pilla Reddy, Pauline Yeo, Evelyn Goh,Anthony Williams, Kee Chuan Goh, Ethirajulu Kantharaj

Signal Transduction Pathways Provide Opportunities to Enhance HDL and apoAI-Dependent Reverse Cholesterol Transport

Journal: Current Pharmaceutical Biotechnology
Volume: 13 Issue: 2 Year: 2012 Page: 352-364
Author(s): Vishwaroop Mulay, Peta Wood, Carles Rentero, Carlos Enrich, Thomas Grewal

The Yin and Yang of Non-Neuronal Î±7-Nicotinic Receptors in Inflammation and Autoimmunity

Journal: Current Drug Targets
Volume: 13 Issue: 5 Year: 2012 Page: 644-655
Author(s): Perla Filippini, Alfredo Cesario, Massimo Fini, Franco Locatelli, Sergio Rutella

Search

Find Journals, Volumes, Issues, Articles, Ebooks and Chapters

Search Result "JAK2-specific inhibitors"